MERIDIAN BIOSCIENCE INC's ticker is VIVO and the CUSIP is 589584101. A total of 174 filers reported holding MERIDIAN BIOSCIENCE INC in Q1 2016. The put-call ratio across all filers is 0.53 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,483,000 | +461.7% | 44,515 | +404.0% | 0.00% | +200.0% |
| Q2 2022 | $264,000 | +17.9% | 8,833 | +3.9% | 0.00% | 0.0% |
| Q1 2021 | $224,000 | -93.1% | 8,499 | -95.4% | 0.00% | -97.1% |
| Q4 2016 | $3,236,000 | +22.1% | 183,196 | +33.1% | 0.04% | +12.9% |
| Q3 2016 | $2,650,000 | +1.4% | 137,674 | +2.6% | 0.03% | -6.1% |
| Q2 2016 | $2,614,000 | +3.8% | 134,203 | +9.7% | 0.03% | +312.5% |
| Q1 2016 | $2,519,000 | +31.9% | 122,315 | +9.7% | 0.01% | -68.0% |
| Q3 2015 | $1,910,000 | +32.3% | 111,530 | +44.0% | 0.02% | +8.7% |
| Q2 2015 | $1,444,000 | +514.5% | 77,450 | +560.3% | 0.02% | +666.7% |
| Q1 2015 | $235,000 | – | 11,730 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SYQUANT CAPITAL SAS | 134,804 | $4,477 | 11.01% |
| Vazirani Asset Management LLC | 115,774 | $3,845 | 6.51% |
| FIFTH LANE CAPITAL, LP | 185,914 | $6,174,204 | 5.56% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 1,939,075 | $64,396,681 | 5.01% |
| Crystalline Management Inc. | 244,453 | $8,118,284 | 4.08% |
| FNY Investment Advisers, LLC | 51,000 | $1,693 | 2.36% |
| HAVENS ADVISORS LLC | 26,800 | $890,028 | 2.26% |
| Euclidean Technologies Management, LLC | 62,995 | $2,092,064 | 1.99% |
| Sand Grove Capital Management LLP | 537,060 | $17,836 | 1.70% |
| Crabel Capital Management, LLC | 120,337 | $3,996 | 1.45% |